Fresenius Medical Care AG (LON: 0H9X)

Market Cap	11.03B
Revenue (ttm)	16.01B
Net Income (ttm)	548.33M
Shares Out	n/a
EPS (ttm)	1.87
PE Ratio	20.12
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	May 17, 2024

Volume	15,114
Average Volume	50,177
Open	44.33
Previous Close	44.68
Day's Range	43.74 - 44.34
52-Week Range	26.92 - 38.27
Beta	0.85
RSI	54.78
Earnings Date	Feb 25, 2025

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 119,845
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0H9X

Financial Performance

In 2023, Fresenius Medical Care AG's revenue was 19.45 billion, an increase of 0.29% compared to the previous year's 19.40 billion. Earnings were 499.00 million, a decrease of -25.90%.

Financial numbers in EUR